Venture Planning Group
Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries. The company’s services include:
- Market Intelligence Surveys
- Opportunity Analyses
- New Technology/Product Assessments
- Acquisition/Joint Venture Evaluations
VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.
... and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, ... diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and ...
May, 2013 820 pages... companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business ... the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world’s major health ...
May, 2013 1600 pages... other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major ... disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. ...
May, 2013 820 pages... from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ...
May, 2013 600 pages... molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, ...
May, 2013 500 pages... market entrants identify and evaluate emerging opportunities in the European blood banking market during the next five years, and to assist industry ... ; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ...
May, 2013 600 pages... next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies ...
May, 2013 970 pages... potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next five years. The ... forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal ...
May, 2013 450 pages... opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses in five countries, assessment of ... the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world’s major health ...
May, 2013 1600 pages... testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction ...
May, 2013 500 pages... introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and ...
May, 2013 970 pages... ; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The clinical chemistry and immunodiagnostics markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic ...
May, 2013 900 pagesHighlights Comprehensive 850-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as ... trends with significant market impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection ...
May, 2013 850 pages... Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers ... volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and ...
May, 2013 61 pagesReport Highlights Comprehensive 409-page analysis of the UK hemostasis market. Major issues pertaining to the UK hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year volume and ...
May, 2013 409 pages... Highlights Comprehensive 405-page analysis of the French hemostasis market. Major issues pertaining to the French hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year volume ...
May, 2013 405 pages... shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
May, 2013 620 pages... Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...
May, 2013 570 pagesHighlights Comprehensive 976-page analysis of the Japanese microbiology testing market. Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
May, 2013 976 pagesHighlights Comprehensive 425-page market segmentation analysis of the transfusion testing market. Major issues pertaining to the Spanish transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
May, 2013 425 pages
